NASDAQ:LUCD
Lucid Diagnostics Inc.
Lucid Diagnostics Inc.'s revenue grew 8.3% in fiscal 2025 to $4.7M while operating margin rose to −1054.8%, its highest in 5 years. Free cash flow was −$46.7M, −992.0% of revenue.Summary generated from Lucid Diagnostics Inc.'s SEC filings. Latest annual report filed Mar 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$4.7M
Revenue growth+8.3%
Revenue, 5-yr CAGRn/a
Gross margin−41.7%
Operating margin−1054.8%
Net margin−1232.7%
ROICn/a
Return on equity−710.6%
Debt / equityn/a
Free cash flow−$46.7M
FCF margin−992.0%
Share count changen/a
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 0 | 2 | 4 | 5 |
| Operating income | −27 | −56 | −48 | −46 | −50 |
| Net income | −28 | −56 | −53 | −46 | −58 |
| Free cash flow | −19 | −33 | n/a | −44 | −47 |
Recent filings
- 8-KRegulation FD disclosure
Sep 22, 2026 - 8-KResults of operations and financial condition
Aug 13, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 12, 2026 - 8-KAmendment to articles or bylaws
Jun 24, 2026 - 4Insider transaction report
May 21, 2026 - 8-KResults of operations and financial condition
May 14, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 13, 2026 - DEF 14AProxy statement
Apr 30, 2026